C
Clementia Pharmaceuticals
Developer of a drug to treat fibrodysplasia ossificans progressiva
About Clementia Pharmaceuticals
Clementia Pharmaceuticals, a subsidiary of Ipsen, operates as a global biopharmaceutical company with a strong focus on developing innovative treatments for oncology, neuroscience, and rare diseases. The company aims to launch at least one new drug or meaningful indication each year, demonstrating a commitment to continuous innovation and patient care. Clementia serves a diverse range of clients, including healthcare providers, patients, and research institutions, primarily in the pharmaceutical and biotechnology markets. The business model revolves around research and development, clinical trials, and commercialization of new therapies. Revenue is generated through the sale of these therapies, partnerships, and collaborations with other pharmaceutical companies. The company leverages its biotech mindset and robust development and commercialization teams to maintain a competitive edge in the market.
Source: Dealroom company dataAt a glance
- Founded
- 2012
- Headquarters
- Montreal, Canada
- Listing
- IPO 2017
- Sector
- Biotech & Life Sciences
- Power Law
- Unicorn$1–10B valuation tier
Latest news
Press, funding announcements and product moves mentioning Clementia Pharmaceuticals.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Series B and later4 investors entered at this stage
Janus Capital Group
NEA
Rock Springs Capital
Fonds de solidarité FTQ
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Patents
3 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Clementia Pharmaceuticals on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Clementia Pharmaceuticals on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.